Abstract: Rapid, simple and sensitive and validated spectrophotometric methods have been developed for the assay of two phosphodiesterase type 5-inhibitors; vardenafil HCl (VARD) and tadalafil (TDF) in pure and dosage forms. The proposed methods were based on the oxidation of both drugs by a known excess of potassium permanganate (KMnO 4 ) in acidic medium and estimating the unreacted permanganate by the reaction with a fixed amount of three dyes, amaranth, indigo carmine and methylene blue, in the same acid medium followed by measuring the absorbance at λ max =520, 610 and 664 nm, respectively. Different variables affecting the reaction were studied and optimized. The beer's law is obeyed in the concentration ranges of 2.0-12, 2.0-15 and 2.0-12 µg mL -1 for VARD and 2.0-15, 2.0-20 and 2.0-12 µg mL -1 for TDF using amaranth, indigo carmine and methylene blue methods, respectively with a correlation coefficient ≥ 0.9992. The apparent molar absorptivity values are in the range 2. L mol -1 cm -1 for TDF, using amaranth, indigo carmine and methylene blue methods, respectively. The limits of detection and quantification are reported. Intra-day and inter-day accuracy and precision of the methods have been evaluated. No interference was observed from the common tablet excipients. The methods were successfully applied to the assay of VARD and TDF in tablet preparations and the results were statistically compared with those of the reported methods by applying Student's t-test and F-test. The reliability of the methods was further ascertained by performing recovery studies using the standard addition method.
Introduction
indole-1,4-dione ( Figure 1 ). VARD and TDF are widely used as a selective phosphodiesterase type 5-inhibitor (PDE5) in the management of erectile dysfunction 1, 2 . Extensive literature survey revealed that the determination of VARD and TDF in pure and dosage forms are not official in any of the pharmacopoeias and therefore, require much more investigation. Few reports for the determination of VARD in pure, tablet dosage forms and biological fluids have been developed with the help of a variety of analytical tools including high performance liquid chromatography (HPLC) [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] , gas chromatography 13, 14 , capillary electrophoresis 15, 16 , electrochemical methods 17, 18 and atomic emission spectrometry [19] [20] [21] . Several analytical methods have been reported for the estimation of TDF in biological fluids or pharmaceutical dosage forms include HPLC [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , liquid chromatography-tandem mass spectrometry with electrospray ionization [35] [36] [37] , micellar electro kinetic capillary chromatography 38 and atomic emission spectrometry 20, 21 .
All the above methods developed for the quantification of VARD and TAD employed complex analytical instruments for their estimation mainly in bulk drug powders, tablet dosage forms and biological fluids. However, most of these methods are complex, require expensive experimental setup and skilled personnel, suffer from time-consuming procedures and are inaccessible to many laboratories in developing and under developed nations. In contrast, visible spectrophotometry is considered as the most convenient analytical technique in most quality control and clinical laboratories, hospitals and pharmaceutical industries for the assay of different classes of drugs in pure, pharmaceutical formulations and biological samples, due to its simplicity and reasonable sensitivity with significant economic advantages.
To the best of our knowledge, there are some methods have been reported for the quantification of VARD and TDF in commercial dosage forms using a spectrophotometric technique [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] (Table 1) . However, these previously reported methods suffer from one or the other disadvantage such as poor sensitivity, depending on critical experimental variables, few methods require a rigid pH control and tedious and time-consuming liquid-liquid extraction step; some other methods have a relatively narrow dynamic linear range, involve a heating step, and/or use of expensive reagent or large amounts of organic solvents. For these reasons, it was worth while to develop a new, simple, cost effective and selective spectrophotometric method for the determination of VARD and TDF their pharmaceutical dosage forms.
The three dyes, amaranth, indigo carmine and methylene blue are well known for their high absorptivity and have been utilized for estimation of excess oxidant. The present work aims to develop a simple, rapid, sensitive, accurate, precise and cost-effective spectrophotometric methods for the estimation of two phosphodiesterase type 5-inhibitors, VARD and TDF in pure and dosage forms based on the discoloring redox reaction with an excess of KMnO 4 and the determination of unreacted oxidant by the decrease in absorbance of the dyes; amaranth, indigo carmine and methylene blue. 
Experimental
All absorption spectra were made using Varian UV-Vis spectrophotometer (Cary 100 Conc., Australia) equipped with 10 mm quartz cell was used for absorbance measurements. This spectrophotometer has a wavelength accuracy of ±0.2 nm with a scanning speed of 200 nm/min and a band width of 2.0 nm in the wavelength range of 200-900 nm.
Materials and reagents
All chemicals, solvents and reagents used in this work were of analytical reagent or pharmaceutical grade and all solutions were prepared fresh daily. Bidistilled water was used throughout the investigation.
Reference standard of pure drugs
Pharmaceutical grade VARD and TDF working standard was kindly supplied by their respective manufactures in Egypt, without any conflicts of interests in our submitted paper.
Pharmaceutical formulations
The following tablets were purchased from local commercial markets. Levitra tablets are labeled to contain 10 mg VARD per tablet (Bayer Health Care Pharmaceuticals, Germany 
Standard solutions
A stock standard solution (100 µg mL -1 ) of VARD and (200 µg mL -1 ) TDF was prepared by dissolving 10 and 20 mg of pure VARD and TDF, respectively in bidistilled water and methanol, respectively further diluted to 100 mL with the same solvent in a 100 mL measuring flask. The standard solutions were found stable for at least one week without alteration when kept in an amber colored bottle and stored in a refrigerator when not in use.
Reagents
Potassium permanganate (KMnO 4 
A stock solution of 5.0x10 -4 mol L -1 KMnO 4 was freshly prepared by dissolving 0.079 g of KMnO 4 (Sigma-Aldrich) in 10 mL of warm bidistilled water then completed to the mark in a 100 mL calibrated flask and standardized using sodiumoxalate 51 and kept in a dark bottle and a refrigerator when not in use.
Sulfuric acid (H
A 2.0 mol L −1 of H 2 SO 4 was prepared by adding 10.8 mL of concentrated acid (Merck, Darmstadt, Germany, 98%) to bidistilled water, cooled to room temperature, transfer to 100 mL with measuring flask, diluted to the mark and standardized as recorded 52 .
Dyes (1000 µg mL -1 )
A stock solutions (1000 µg mL -1 ) amaranth, indigo carmine and methylene blue were first prepared by dissolving accurately weighed 112 mg of each dye (Sigma-aldrish, 90% dye content) in bidistilled water and diluting to volume in a 100 mL calibrated flask. The solution was then diluted 5.0-fold and 10-fold to get the working concentration of 200 and 100 µg mL -1 of (amaranthor indigocarmine) and methylene blue, respectively.
Recommended general procedures
For VARD Different aliquots (0.2-1.2 mL), (0.2-1.5 mL) and (0.2-1.2 mL) of a standard 100 µg mL -1 VARD solution using amaranth, indigo carmine and methylene blue methods, respectively, were transferred into a series of 10 mL calibrated flasks followed by adding 1.0 mL 2.0 mol L -1 H 2 SO 4 and 1.5 mL of KMnO 4 solution (5.0x10 -4 mol L -1 ) were added successively. The flasks were stoppered, content mixed and the flasks were kept aside for 5.0 min with occasional shaking. Finally, 1.5 mL of (200 µg mL -1 ) amaranth, indigo carmineor methylene blue solution was added to each flask and mixed well and then the volume was diluted to the mark with water. The decrease in color intensity of dyes were measure dspectrophotometrically after 3.0 min against a blank solution containing the same constituent except drug treated similarly, at their corresponding λ max 520, 610 and 664 nm for amaranth, indigo carmine and methylene blue methods, respectively. The concentration range was determined in each case by plotting the concentration of VARD against absorbance at the corresponding maximum wavelengths.
For TDF
Different aliquots (0.2-1.5 mL), (0.2-2.0 mL) and (0.2-1.2 mL) of a standard 100 µg mL -1 TDF solution using amaranth, indigocarmine and methylene blue methods, respectively, were transferred into a series of 10 mL calibrated flasks followed by adding 1.0 mL 2.0 mol L -4 mol L -1 ) using methylene blue and (amaranth or indigocarmine), respectively were added successively. The flasks were stoppered, content mixed and the flasks were kept aside for 5.0 min with occasional shaking. Finally, 1.0, 1.2 and 1.5 mL of (200 µg mL -1 ) amaranth, indigo carmine and methylene blue solution, respectively were added to each flask and mixed well and then the volume was diluted to the mark with water. The decrease in color intensity of dyes were measured spectrophotometrically after 3.0 min against a blank solution containing the same constituent except drug treated similarly, at their corresponding λ max 520, 610 and 664 nm for amaranth, indigo carmine and methylene blue methods, respectively. The concentration range was determined in each case by plotting the concentration of TDF against absorbance at the corresponding maximum wavelengths.
Procedure for pharmaceutical formulations (tablets)
The contents of twenty tabletsof each drug were weighed accurately and ground into a fine powder. An accurate weight of the powdered tablets equivalent to 20 mg VARD was dissolved in bidistilled water or 20 mg TDF was dissolved in methanol with shaking for 5.0 min and filtered using a Whatman No. 42 filter paper. The filtrate was diluted to the mark with bidistilled water for VARD or methanol for TDF in a 100 mL measuring flask to give and 200 µg mL -1 stock solution of VARD or TDF for analysis by spectrophotometric methods. A convenient aliquot was then subjected to analysis by the spectrophotometric procedures described above to determine the nominal content of the tablets using the corresponding regression equation of the appropriate calibration graph.
Results and Discussion

Absorption spectra
The spectrophotometric method for the determination of VARD and TDF involves two steps namely:
1. Oxidation of the studied drugs with a known excess of KMnO 4 in acidic medium at room temperature (25±2 °C). 2. Determination of the residual KMnO 4 by reacting it with a fixed amount of amaranth, indigocarmine and methylene blue dyes and measuring the absorbance of dyes at λ max 520, 610 and 664 nm for amaranth, indigocarmine and methylene blue methods, respectively ( Figure 2 ).
Figure 2.
Absorption spectra for the unreacted oxidant that determined by reacting with a fixed amount of dyes and measuring the absorbance at 520, 610 and 664 nm for amaranth, indigocarmine and methylene blue methods, respectively in case of VARD These methods make use of the bleaching action of KMnO 4 on the dyes, the decolorization being caused by the oxidative destruction of the dyes. VARD or TDF when added in increasing concentrations to a fixed concentration of KMnO 4 consumes the latter proportionally and there will be a concomitant decrease in the concentration of KMnO 4 . When a fixed concentration of dye is added to decreasing concentrations of KMnO 4 , a concomitant increase in the concentration of dye is obtained. Consequently, a proportional increase in the absorbance at the respective λ max is observed with increasing concentrations of VARD or TDF. The tentative reaction scheme of spectrophotometric methods is shown in Scheme 1.
Known excess of KMnO 4 H + Reaction product of drug Unreacted KMnO 4 Drug
Unreacted KMnO 4 Amaranth method M e t h y l e n e b l u e M e t h o d 
Optimization of variables
The optimum conditions for the assay procedures and color development for each method have been established by varying the parameters one at a time, keeping the others fixed and observing the effect produced on the absorbance of the colored species.
Effect of acid type and concentration
To study the effect of acid concentration, different types of acids were examined (H 2 SO 4 , H 3 PO 4 and CH 3 COOH) to achieve maximum yield of redox reaction. The results indicated that the sulphuric acid (H 2 SO 4 ) was the most suitable acid with KMnO 4 as oxidant. Moreover, different volumes (0.2-3.0 mL) of 2.0 mol L -1 H 2 SO 4 were tested and found to be 1.0 mL of 2.0 mol L -1 H 2 SO 4 was ideal for the oxidation step in three methods and the same quantity of acid was employed for the estimation of the dye.
Effect of KMnO 4 concentration
The influence of the volume of 5.0x10 −4 mol L -1 KMnO 4 on the reaction has been studied. It is apparent from Figure 3 , that the absorbance increased with increasing volume of 5.0x10 −4 mol L -1 KMnO 4 solution from (0.25-3.0 mL) and reached maximum when 1.5 mL of KMnO 4 was added to a total volume of 10 mL forVARD ( Figure 3 ) and 1.0 and 1.5 mL of KMnO 4 solution were added to the total volume of 10 mL for TDF using methylene blue and (amaranth or indigocarmine), respectively.Therefore, it was found that maximum color intensity of the products was achieved with 1.5 mL of 5.0x10 −4 mol L -1 KMnO 4 for all measurements. 
Effect of dye concentration
The effect of amaranth, indigo carmine and methylene blue concentration on the intensity of the color developed was carried out to obtain the optimum concentration of dyes that produces the maximum and reproducible color intensity by reducing the residual of KMnO 4 . The effect dye concentration was studied in the range of 0.25-3.0 mL of each dye (200 µg mL -1 ). It was found that maximum color intensity of the oxidation products was achieved with 1.5
Volume of, 5.0x10 -4 mol L -1 , KMnO4, mL Absorbance of each dye solution in case of VARD (Figure 4 ). Whereas, it was found that maximum color intensity of the oxidation products was achieved with 1.0, 1.2 and 1.5 mL of amaranth, indigo carmine and methylene blue dye solutions, respectively for TDF ( Figure 5 ). The color was found to be stable up to 24 h. 
Effect of temperature and mixing time
The effect of temperature was studied by heating a series of sample and blank solutions at different temperatures ranging from 25 to 60 °C in water bath. It was found that raising the temperature does not accelerate the oxidation process and does not give reproducible results, so maximum color intensity was obtained at room temperature (25±2 °C). The effect of mixing time required completing oxidation of the studied drugs and for reducing the excess oxidant was studied by measuring the absorbance of sample solution against blank solution prepared similarly at various time intervals 2.0-20 min. It was found that the contact times gave constant and reproducible absorbance values at 5.0 min at room temperature (25±2 °C) Absorbance for both drugs. The time required for complete oxidation of the drug is not critical and any delay up to 15 min in the determination of unreacted KMnO 4 had no effect on the absorbance. After oxidation process, 3.0 min standing time was found necessary for the complete bleaching of the dye color by the residual KMnO 4 for both drugs and the absorbance of the unreacted dye was stable for at least 24 h, there after.
Effect of sequence of addition
The optimum sequence of addition was KMnO 4 -H 2 SO 4 -drug-dye. Other sequences gave lower absorbance values under the same experimental conditions. Table 2 .
Stoichiometric ratio
Method validation
The proposed methods have been validated for linearity, sensitivity, precision, accuracy, selectivity and recovery.
Linearity and sensitivity
Under the optimum conditions a linear correlation was found between absorbance at λ max and the concentration of VARD and TDF in the ranges of 2.0-15 and 2.0-20 µg mL -1 , respectively. The calibration graph is described by the equation: A = a + b C (1) Where A= absorbance, a= intercept, b= slope and C= concentration in µg mL -1 , obtained by the method of least squares. Correlation coefficient, intercept and slope of the calibration data are summarized in Table 2 . For accurate determination, Ringbom concentration range 54 was calculated by plotting log concentration of drug in µg mL -1 against transmittance % from which the linear portion of the curve gives an accurate range of micro determination of VARD and TDF and represented in Table 2 . Sensitivity parameters such as apparent molar absorptivity and Sandell's sensitivity values, as well as the limits of detection and quantification, were calculated as per the current ICH guidelines 55 and illustrated in Table 2 . The high molar absorptivity and lower Sandell sensitivity values reflect the good and high sensitivity of the proposed methods. The validity of the proposed methods was evaluated by statistical analysis 56 between the results achieved from the proposed methods and that of the reported method. Regarding the calculated Student's t-test and variance ratio F-test (Table 2) , there is no significant difference between the proposed and reported methods 40, 47 regarding accuracy and precision. The theoretical values of t and F are 2.57 and 5.05, respectively at confidence limit at 95% confidence level and five degrees of freedom (p= 0.05).
The limits of detection (LOD) and quantification (LOQ) were calculated according to the same guidelines using the formulas 55, 56 :
LOD=3.3σ/s and LOQ=10σ/s
Where σ is the standard deviation of five reagent blank determinations and s is the slope of the calibration curve.
Accuracy and precision
In order to evaluate the precision of the proposed methods, solutions containing three different concentrations of VARD and TDF were prepared and analyzed in six replicates. The analytical results obtained from this investigation are summarized in Table 3 & 4. Lower values of the relative standard deviation (R.S.D%) and percentage relative error (R.E%) indicate the precision and accuracy of the proposed methods. The percentage relative error is calculated using the following equation:
The assay procedure was repeated six times and percentage relative standard deviation (R.S.D%) values were obtained within the same day to evaluate repeatability (intra-day precision) and over five different days to evaluate intermediate precision (inter-day precision).
For the same concentrations of drugs inter-and intra-day accuracy of the methods was also evaluated. The percentage recovery values with respect to found concentrations of each drug were evaluated to ascertain the accuracy of the methods. The recovery values close to 100% as compiled in Table 3 & 4 shows that the proposed methods are very accurate. 
Robustness and ruggedness
For the evaluation of method robustness, volume of H 2 SO 4 was slightly altered (1.0±0.2 mL) and the reaction timewas slightly varied deliberately (5.0±2.0 min) (after adding KMnO 4 ) in the three methods for each drug. The analysis was performed with altered conditions by taking three different concentrations of drugs and the methods were found to remain unaffected as shown by the RSD values in the ranges of 0.75-2.40% and 0.70-2.20% for VARD and TDF, respectively. Methods ruggedness was expressed as the RSD of the same procedure applied by three different analysts as well as using three different instruments (spectrophotometers). The inter-analysts RSD were in the ranges 0.80-2.20% and 0.60-1.95% for VARD and TDF, respectively, whereas the inter-instruments RSD ranged from 0.80-2.40% and 0.90-2.30% for VARD and TDF, respectively suggesting that the developed methods were rugged. The results are shown in Table 5 . 
Recovery studies
To ascertain the accuracy, reliability and validity of the proposed methods, recovery experiment was performed through standard addition technique. This study was performed by spiking three different levels of pure drugs (50, 100 and 150% of the level present in the tablet) to a fixed amount of drugs in tablet powder (pre-analysed) andthe total concentration was found by the proposed methods. The determination with each level was repeated three times and the percent recovery of the added standard was calculated from:
Where C F is the total concentration of the analyte found, C T is a concentration of the analyte present in the tablet preparation; C P is a concentration of analyte (pure drugs) added to tablets preparations. The results of this study presented in Table 6 revealed that the accuracy of the proposed methods was unaffected by the various excipients present in tablets which did not interfere in the assay. 
Application of pharmaceutical formulations (tablets)
The proposed methods were applied to the determination of VARD and TDF in pharmaceutical formulations (tablets). The results in Table 7 showed that the methods are successful for the determination of VARD and TDF and that the excipients in the dosage forms do not interfere. A statistical comparison of theresults obtained from the assay of VARD and TDF by the proposed methods and the reported methods 40, 47 for the same batch of material is presented in Table 7 . The results agree well with the label claim and also were in agreement with the results obtained by the reported methods 40, 47 . When the results were statistically compared with those of the reported methods by applying the Student ' s t-test for accuracy and F-test for precision, the calculated t-value and F-value at 95% confidence level did not exceed the tabulated values for five degrees of freedom 56 . Hence, no significant difference between the proposed methods and the reported methods at the 95% confidence level with respect to accuracy and precision. 
Conclusion
Three new, useful simple, rapid, and cost-effective spectrophotometric methods have been developed for determination of VARD and TDF in bulk drugs and in their tablets using KMnO 4 as oxidizing agent and validated as per the current ICH guidelines. The present spectrophotometric methods are characterized by simplicity of operation, high selectivity, comparable sensitivity, low-cost instrument, they do not involve any critical experimental variable and are free from tedious and time-consuming extraction steps and use of organic solvents unlike many of the previous methods reported for VARD and TDF. The assay methods have some additional advantages involve less stringent control of experimental parameters such as the stability of the colored system, accuracy, reproducibility, time of analysis, temperature independence and cheaper chemicals. These advantages encourage the application of the proposed methods in routine quality control analysis of VARD and TDF in pure and dosage forms.
